Theravance Biopharma Inc
NASDAQ:TBPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Theravance Biopharma Inc
NASDAQ:TBPH
|
KY |
|
H
|
Hankuk Steel Wire Co Ltd
KOSDAQ:025550
|
KR |
|
Aerometrex Ltd
ASX:AMX
|
AU |
|
W
|
Wanted Lab Inc
KOSDAQ:376980
|
KR |
|
Colgate-Palmolive Co
NYSE:CL
|
US |
|
Astrotech Corp
F:SP5
|
US |
|
Yunfeng Financial Group Ltd
F:MNA1
|
HK |
|
E
|
Entravision Communications Corp
F:EV9
|
US |
Intrinsic Value
Is TBPH undervalued or overvalued?
See the intrinsic value estimate for Theravance Biopharma Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
TBPH looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with TBPH’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Theravance Biopharma Does
Theravance Biopharma is a biopharmaceutical company that develops and commercializes medicines for lung disease and certain serious infections. Its best-known products are treatments for chronic obstructive pulmonary disease and hospital or community bacterial infections, with a focus on patients who need inhaled or hospital-use therapies rather than broad primary-care drugs.
- Headquarters
- Cayman Islands KY
- Employees
- 90
- IPO date
- May 16, 2014
Revenue & Expenses Breakdown
Theravance Biopharma Inc
Earnings Waterfall
Theravance Biopharma Inc
The intrinsic value for Theravance Biopharma Inc (TBPH) under the Base Case is hidden USD.
Compared with the current market price of 17.03 USD, the stock appears hidden.